Epigenetic regulation of drug processing genes

Area of Science:

• Pharmacology and Toxicology
• Molecular Biology
• Epigenetics

Background:

• Drug processing genes (DPGs) control xenobiotic absorption, distribution, metabolism, and excretion.
• Nuclear receptors/transcription factors regulate DPG expression.
• Epigenetic mechanisms, including DNA methylation, histone modifications, and microRNAs, are increasingly recognized as regulators of DPGs and nuclear receptors.

Purpose of the Study:

• To summarize current knowledge on the epigenetic regulation of DPGs and nuclear receptors.
• To highlight the role of epigenetics in tissue-specific gene expression.
• To examine epigenetic influences on gene expression during development and carcinogenesis.

Main Methods:

• Literature review and synthesis of existing research on epigenetic regulation of DPGs and nuclear receptors.
• Analysis of studies focusing on DNA methylation, histone modifications, and microRNA involvement.
• Examination of data related to tissue-specific expression, developmental changes, and cancer-related alterations.

Main Results:

• Epigenetic mechanisms significantly influence the expression of DPGs and nuclear receptors.
• These epigenetic modifications are critical for establishing and maintaining tissue-specific gene expression patterns.
• Alterations in epigenetic regulation of DPGs and nuclear receptors are implicated in developmental processes and the development of cancer.

Conclusions:

• Epigenetic regulation is a key determinant of DPG and nuclear receptor function.
• Understanding these epigenetic mechanisms is vital for comprehending xenobiotic metabolism, normal development, and disease pathogenesis, particularly cancer.
• Further research into epigenetic modifications offers potential therapeutic targets for diseases involving altered drug metabolism.